Groups

Research Focus

Former Employee. David H . Koch Center; Clinical Nurse III

Recent additions – View all

1. Cobimetinib-induced “dropped head syndrome” and subsequent disease management in an Erdheim-Chester patient

   Journal Article

   King, A. C.; Diamond, E. L.; Orozco, J. S.; Morse, H. R.; Ouyang, L. L.; Schöder, H.; Rampal, R. K.
   Clinical Case Reports (2019)

   Fulltext@MSK | Save
2. Tumor lysis, adverse events, and dose adjustments in 297 venetoclax-treated CLL patients in routine clinical practice

   Journal Article

   Roeker, L. E.; Fox, C. P.; Eyre, T. A.; Brander, D. M.; Allan, J. N.; Schuster, S. J.; Nabhan, C.; Hill, B. T.; Shah, N. N.; Lansigan, F.; more...
   Clinical Cancer Research (2019)

   Fulltext@MSK | Save
3. Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL)

   Meeting Abstract

   Sarraf Yazdy, M.; Roeker, L.; Gashonia, L.; Goodfriend, J.; Narkhede, M.; Rhodes, J.; Kennard, K.; Morse, H.; Dorsey, C.; Battiato, K.; more...
   Hematological Oncology (2019)

   Fulltext@MSK | Save